MedTrace Logo

Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points.

NCT06241404 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-02-05

No results posted yet for this study

Summary

Background: Shoulder pain commonly affects the general population, with rotator cuff tendinopathy being the most common cause.

the most common cause, with rotator cuff tendinopathy diminishing function and quality of life, leading to a major socio-economic impact.

quality of life, leading to a major socio-economic impact. As a result, there are two treatment approaches with potential effectiveness: therapeutic exercise (TE) and myofascial trigger point treatment (TMT).

trigger point treatment (TTP).

Objective: The main objective of this randomised clinical trial is to determine the efficacy of ET versus treatment of MTPs in shoulder tendinopathies.

Methods: For this study, 20 participants were randomly divided into two groups: a ET group, with which a 10-exercise programme was initiated (n = 10), and a PGM group which was given an intervention protocol (n = 10).

intervention protocol (n = 10). Both received a total of 10 sessions. Pain intensity pain intensity, pressure pain threshold (PPT) and range of motion (ROM) were assessed before starting and after 10 sessions.

and after 10 sessions.

Conditions

  • Shoulder Tendinopathy

Interventions

PROCEDURE

trigger point therapy

patients who have been treated for shoulder tendinopathy by trigger point therapy

PROCEDURE

Exercise therapy

patients who have been treated for shoulder tendinopathy by exercise therapy

Sponsors & Collaborators

  • Universidad Católica de Ávila

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2023-11-01
Completion
2024-01-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06241404 on ClinicalTrials.gov